Orthopediatrics (KIDS) EBT Growth (1y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -18.50% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 11.26% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -8.83% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.35% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 5.78% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 103.34% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 74.66% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -27.02% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 54.33% |
| 10 | Orthopediatrics | 394.83 Mn | 346.02 Mn | 43.39 Mn | -3.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.78% |
| Dec 31, 2025 | 40.50% |
| Sep 30, 2025 | -30.22% |
| Jun 30, 2025 | -16.82% |
| Mar 31, 2025 | -1.23% |
| Dec 31, 2024 | -137.71% |
| Sep 30, 2024 | -144.17% |
| Jun 30, 2024 | -83.97% |
| Mar 31, 2024 | -40.05% |
| Dec 31, 2023 | 12.58% |
| Sep 30, 2023 | -125.99% |
| Jun 30, 2023 | -325.78% |
| Mar 31, 2023 | 21.63% |
| Dec 31, 2022 | -4,656.63% |
| Sep 30, 2022 | 678.38% |
| Jun 30, 2022 | 80.90% |
| Mar 31, 2022 | 11.92% |
| Dec 31, 2021 | 98.87% |
| Sep 30, 2021 | 45.16% |
| Jun 30, 2021 | 57.21% |
| Mar 31, 2021 | -116.20% |
| Dec 31, 2020 | -240.40% |
| Sep 30, 2020 | -57.77% |
| Jun 30, 2020 | -284.18% |
| Mar 31, 2020 | -63.74% |
| Dec 31, 2019 | -131.99% |
| Sep 30, 2019 | -145.48% |
| Jun 30, 2019 | -15.99% |
| Mar 31, 2019 | 32.10% |
| Dec 31, 2018 | 61.42% |
| Sep 30, 2018 | 22.64% |
| Jun 30, 2018 | -213.15% |
| Mar 31, 2018 | -429.52% |
| Dec 31, 2017 | -31.73% |
| Sep 30, 2017 | -64.14% |